David Linetsky, SVP, Life Sciences at Phreesia, Inc. (PHR), sold 127 shares at $27.85 ($4K) on 2025-03-19, disclosed to the SEC on 2025-03-20.
Open-market sale of $4k PHR by SVP, Life Sciences. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.95 | 39 | $1K | 30.0% |
| 2 | $27.85 | 81 | $2K | 64.4% |
| 3 | $28.31 | 7 | $198 | 5.7% |
| Total | $27.60 avg | 127 | $4K | 100% |
| Filing → |
| PHR | SELL | 2026-01-20 | $127K | — | Filing → |
| PHR | SELL | 2026-01-12 | $104K | — | Filing → |
| PHR | SELL | 2025-12-19 | $2K | — | Filing → |